Who we are Request information Case studies News & Events Career Investors Information portal Switzerland instrument Test portfolio Connectivity Testing in action Customer service Fast Lab Solutions Transforming near-patient health care with a next-generation point-of-care diagnostic platform Results comparable to laboratory methods in minutes Leverages test methods used in laboratory analysis systems and enables healthcare providers to deliver laboratory-like performance and real-time results at the point of care. Broad test portfolio Economic benefit Our highly sensitive LumiraDx platform. A next-generation point-of-care diagnostic system - with a small, portable instrument, microfluidic test strips, a standardized, simple test procedure and a seamless, secure digital connection to the cloud and stationary IT systems. Latest LumiraDx and CA Healthcare Acquisition Corp Revise Transaction Terms, Expanded Strategic Roadmap for Next-Generation Point-of-Care Diagnostics Mehr lesen Ergebnisse schnell verfügbar Mit Labormethoden vergleichbare Ergebnisse in Minuten aus einer kleinen Probe INSTRUMENT ANSEHEN Sofort-Testung Aktuell verfügbar sind Tests auf SARS-CoV-2 Antigen und -Antikörper, D-Dimer und INR. Mehr als 30 Tests unterschiedlicher Testtechnologien, wie Enzymatische Assays, Immunoassays, molekulare und Elektrolyt-Assays befinden sich in der Pipeline. Alle werden auf einem einzigen, einfach anzuwendenden Gerät durchgeführt. TEST-PORTFOLIO ANSEHEN SARS-CoV-2 Ag SARS-CoV-2 Ag Pool Test SARS-CoV-2 Ab D-Dimer INR Digital angebunden Unsere neueste Cloud-basierte Technologie unterstützt Gesundheitsexperten mit Data Reportings, Analysen und Entscheidungen bei geringem Aufwand. KONNEKTIVITÄT ANSEHEN Unsere Point-of-Care-Platform ist als kosteneffiziente und leicht zugängliche Lösung konzipiert. Notaufnahme Ambulante Versorgung Gesundheitseinrichtung Vor-Ort-Apotheke ALLE NEUIGKEITEN ANSEHEN LumiraDx receives approval for its COVID-19 Antigen Test for use in India Mehr lesen LumiraDx to Become Publicly Traded following Successful Closing of Merger with CA Healthcare Acquisition Corp. Mehr lesen LumiraDx and CA Healthcare Acquisition Corp Revise Transaction Terms, Expanded Strategic Roadmap for Next-Generation Point-of-Care Diagnostics Mehr lesen JETZT ANFRAGEN Sie wollen zu aktuellen Entwicklungen bei LumiraDx auf dem Laufenden bleiben? Bessere Gesundheit We support healthier lives for individuals, communities, and society as a whole. Who we are Request information Case studies News & Events Career Investors instrument Test portfolio Connectivity Testing in action Customer service Fast Lab Solutions Legal information Terms of Use Conditions Data protection imprint Our Code of Conduct Gender Pay Gap Report Modern slavery Intellectual property Care Solutions UK headquarters LumiraDx Limited 3 More London Riverside London SE1 2AQ United Kingdom Company Number: 09206123 Branch in Switzerland LumiraDx AG Bahnhofstrasse 25 5504 Othmarsingen CH-020.4.061.445-0 Facebook LinkedIn Twitter © 2021 LumiraDx. All rights reserved worldwide. Registration number: 09206123. Cookies on this website Our website uses cookies and other technologies so that we can remember you and understand how you and other visitors use our website.Visit our privacy policy to find out more or to change your personal settings in our cookie control tool manage. By using our website you agree to our use of cookies. Accept Cookie settings